Provident Financial plc buy krebskrebs
Start price
15.06.20
/
50%
€2.16
Target price
04.11.21
€3.00
Performance (%)
91.09%
End price
05.11.21
€4.12
Summary
This prediction ended on 05.11.21 with a price of €4.12. With a performance of 91.09% the BUY prediction by krebskrebs was a big success. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Provident Financial plc | 9.431% | 9.431% | -75.977% | -78.345% |
iShares Core DAX® | 2.749% | 4.620% | 17.121% | 21.210% |
iShares Nasdaq 100 | 0.470% | -0.331% | 37.776% | 57.865% |
iShares Nikkei 225® | -2.930% | -5.556% | 12.185% | 8.407% |
iShares S&P 500 | 0.679% | 0.631% | 28.996% | 48.197% |
Comments by krebskrebs for this prediction
In the thread Provident Financial plc diskutieren
Buy mit Kursziel 3,0
In the thread Trading Provident Financial plc
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten